These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36625513)

  • 1. Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling.
    Baron M; Barbacki A; Man A; de Vries-Bouwstra JK; Johnson D; Stevens W; Osman M; Wang M; Zhang Y; Sahhar J; Ngian GS; Proudman S; Nikpour M;
    Rheumatology (Oxford); 2023 Sep; 62(9):3059-3066. PubMed ID: 36625513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling.
    Barbacki A; Baron M; Wang M; Zhang Y; Stevens W; Sahhar J; Proudman S; Nikpour M; Man A;
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):640-647. PubMed ID: 35226416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort.
    Foeldvari I; Klotsche J; Kasapcopur O; Adrovic A; Terreri MT; Sakamoto AP; Stanevicha V; Sztajnbok F; Anton J; Feldman B; Alexeeva E; Katsicas M; Smith V; Avcin T; Marrani E; Kostik M; Lehman T; Sifuentes-Giraldo WA; Vasquez-Canizares N; Appenzeller S; Janarthanan M; Moll M; Nemcova D; Patwardhan A; Santos MJ; Sawhney S; Schonenberg-Meinema D; Battagliotti C; Berntson L; Bica B; Brunner J; Costa-Reis P; Eleftheriou D; Harel L; Horneff G; Kaiser D; Kallinich T; Lazarevic D; Minden K; Nielsen S; Nuruzzaman F; Uziel Y; Helmus N; Torok KS
    Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1575-1584. PubMed ID: 33787070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation.
    van den Hombergh WM; Carreira PE; Knaapen-Hans HK; van den Hoogen FH; Fransen J; Vonk MC
    Rheumatology (Oxford); 2016 Nov; 55(11):2023-2032. PubMed ID: 27550299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in disability and their relationship with skin thickening, in diffuse and limited cutaneous systemic sclerosis: a retrospective cohort study.
    Peytrignet S; Manning J; Wragg E; Moore T; Samaranayaka M; Dinsdale G; Herrick AL
    Scand J Rheumatol; 2019 May; 48(3):230-234. PubMed ID: 30394164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
    Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
    Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.
    Allanore Y; Bozzi S; Terlinden A; Huscher D; Amand C; Soubrane C; Siegert E; Czirják L; Carreira PE; Hachulla E; Zanatta E; Li M; Airò P; Mendoza FA; Rosato E; Distler O;
    Arthritis Res Ther; 2020 Oct; 22(1):257. PubMed ID: 33115544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function.
    Purevsuren M; Uehara M; Ishizuka M; Suzuki Y; Shimbo M; Kakuda N; Ishii S; Sumida H; Miyazaki M; Yamashita T; Yoshizaki A; Asano Y; Sato S; Hatano M; Komuro I
    J Cardiol; 2023 Aug; 82(2):100-107. PubMed ID: 36921691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of limited hand mobility in systemic sclerosis patients by using "prayer sign" and "tabletop sign".
    Uslu S; Gülle S; Can G; Sarı İ; Önen F; Birlik M
    Clin Rheumatol; 2021 Jul; 40(7):2771-2777. PubMed ID: 33555460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold digital capillaroscopic findings in patients with diffuse and limited cutaneous systemic sclerosis.
    Shenavandeh S; Haghighi MY; Nazarinia MA
    Reumatologia; 2017; 55(1):15-23. PubMed ID: 28386138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
    Zanatta E; Huscher D; Ortolan A; Avouac J; Airò P; Balbir-Gurman A; Siegert E; Matucci Cerinic M; Cozzi F; Riemekasten G; Hoffmann-Vold AM; Distler O; Gabrielli A; Heitmann S; Hunzelmann N; Montecucco C; Morovic-Vergles J; Ribi C; Doria A; Allanore Y;
    Rheumatology (Oxford); 2022 Nov; 61(12):4786-4796. PubMed ID: 35348643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.
    Li Z; Xu D; Jiang X; Li T; Su Y; Mu R
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registry.
    Freitas R; Martins P; Dourado E; Santiago T; Guimarães F; Fernandes BM; Garcia S; Samões B; Pinto AS; Gonçalves N; Lourenço MH; Costa E; Rocha M; Couto M; Duarte AC; Araújo F; Cordeiro I; Godinho F; Resende C; Salvador MJ; Cordeiro A; Santos MJ
    ARP Rheumatol; 2022; 1(1):21-29. PubMed ID: 35633574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.